Matches in Nanopublications for { ?s ?p "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP206833.RAUUsvC-iNqxhJP38m8Y-qCgMGanp5XleM_3v7oSil4tI130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206833.RAUUsvC-iNqxhJP38m8Y-qCgMGanp5XleM_3v7oSil4tI130_provenance.
- NP131060.RAZZTaDO2L5JeUHKo24mct_vYzOcK2u3INi18isDjTYI0130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131060.RAZZTaDO2L5JeUHKo24mct_vYzOcK2u3INi18isDjTYI0130_provenance.
- NP114501.RAApPnHvd8gOKThEuu7ZBbaywpB50P33SicjJBa_tvP5w130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114501.RAApPnHvd8gOKThEuu7ZBbaywpB50P33SicjJBa_tvP5w130_provenance.
- NP114503.RA6_X_FrwYc2Ua4b90aFO6NkWQukCyrv5AMhIi2d2FnjE130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114503.RA6_X_FrwYc2Ua4b90aFO6NkWQukCyrv5AMhIi2d2FnjE130_provenance.
- NP637054.RA-SayngHzsIv2I8rEo6TghCvw0yFNqoK3mdQBP2mN69A130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637054.RA-SayngHzsIv2I8rEo6TghCvw0yFNqoK3mdQBP2mN69A130_provenance.
- assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP558125.RAMjt2cNzMvQxxBVMAvrSsI_a6XfQsoKLMSxO_tB__7SU130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558125.RAMjt2cNzMvQxxBVMAvrSsI_a6XfQsoKLMSxO_tB__7SU130_provenance.
- NP131062.RAib2ki1nmB3AKeknoequ_Gw6dZ0CoxYVVC-ynBGcaI1g130_assertion description "[Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131062.RAib2ki1nmB3AKeknoequ_Gw6dZ0CoxYVVC-ynBGcaI1g130_provenance.